Teleflex Inc. Reaches New 12-Month High at $87.65 (TFX)
Teleflex (NYSE:TFX)’s share price reached a new 52-week high during mid-day trading on Thursday, AmericanBankingNews.com reports. The stock traded as high as $87.65 and last traded at $86.49, with a volume of 92,525 shares traded. The stock had previously closed at $87.33.
TFX has been the subject of a number of recent research reports. Analysts at JMP Securities initiated coverage on shares of Teleflex in a research note to investors on Wednesday, September 18th. They set an “outperform” rating and a $94.00 price target on the stock. Separately, analysts at Raymond James upgraded shares of Teleflex from a “market perform” rating to an “outperform” rating in a research note to investors on Monday, September 16th. They now have a $92.00 price target on the stock. Finally, analysts at TheStreet upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research note to investors on Tuesday, September 10th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Teleflex currently has an average rating of “Buy” and an average target price of $87.86.
Teleflex has a 1-year low of $65.07 and a 1-year high of $87.46. The stock’s 50-day moving average is $77.67 and its 200-day moving average is $79.51. The company has a market cap of $3.553 billion and a P/E ratio of 30.39.
Teleflex (NYSE:TFX) last released its earnings data on Wednesday, July 31st. The company reported $1.27 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.16 by $0.11. The company had revenue of $420.10 million for the quarter, compared to the consensus estimate of $432.18 million. During the same quarter in the prior year, the company posted $1.23 earnings per share. The company’s quarterly revenue was up 9.6% on a year-over-year basis.
Teleflex Incorporated (NYSE:TFX) is a global provider of medical technology products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.